Development of Digital Biomarkers and Endpoints for Clinical Cancer Care
This grant opportunity focuses on developing digital health technologies (DHTs) for cancer care, specifically to create digital biomarkers and endpoints that improve patient monitoring and outcomes. The grant supports Direct-to-Phase II proposals, not Fast-Track, with 2-4 anticipated awards. Phase I funding is up to $400,000 for 12 months, and Phase II is up to $2,250,000 for 2 years. The goal…
Fast-Track proposals will NOT be accepted.\nDirect-to-Phase II proposals will be accepted.\nNumber of anticipated awards: 2-4\nBudget (total costs, per award):\nPhase I: up to $400,000 for up to 12 months\nPhase II: up to $2,250,000 for up to 2 years\nPROPOSALS THAT EXCEED THE BUDGET OR PROJECT …
Funding Source
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers